What's New

OklahomaMAT Monthly Newsletter

The most recent three OklahomaMAT monthly Newsletters are available now, click HERE!

Register Today! Fundamentals of Addiction Medicine ECHO Begins Dec 4

The American Society of Addiction Medicine (ASAM) and the University of New Mexico Project ECHO are hosting the next FAME series starting December 4th. This FREE series will be held weekly on Tuesdays, 10:00AM – 12:00PM (CT)  Register now! For more details, click HERE!

ASAM Fundamentals of Addiction Medicine 40-Hour CME Program is Available for FREE!

As an OklahomaMAT provider, you can access the ASAM Fundamentals of Addiction Medicine 40-Hour CME Program at no cost. Participants will learn how to recognize, screen, treat and refer patients with substance use disorders. If you have not received an email to confirm your registration, please email: OklahomaMAT@air.org.

Treatment WORKS!

Read provider clinical success stories in the treatment of opioid use disorder from ASAM and the Providers Clinical Support System. These stories from the field will provide you with context on how buprenorphine and other measures are helping to curb the epidemic.

Welcome

Welcome to the Oklahoma Medication-Assisted Treatment (MAT) Expansion Project. This project aims to expand access to MAT for persons with opioid use disorder (OUD) by training and supporting rural primary care practices in Oklahoma. Medication-Assisted Treatment is an evidence-based strategy for treating persons with OUD. MAT combines the use of medications with counseling and behavior therapies to provide a whole-patient approach to treatment.

About Oklahoma Rural MAT Expansion

The Problem

Prescription drug overdoses kill nearly two Oklahomans per day.
In many rural Oklahoma counties, opioids account for more than half of drug overdose deaths.
Oklahoma lacks access to treatment for OUD, particularly in rural areas where there are few primary care
providers trained to identify and treat people who are opioid dependent. Many Oklahoma providers are
concerned about the devastating effect on their patients and communities.
However, many providers also feel overwhelmed at the prospect of offering treatment for OUD in their own practice.
Click here for more information about opioid addiction in Oklahoma.

What We Offer

We offer practical, hands-on assistance to you and your office team through training, case-based
consultations with addiction specialists, and mentoring from experienced medication-assisted treatment providers.
Primary care physicians, nurse practitioners and physician assistants can receive certification and appropriate
waivers to treat and manage opioid dependent patients in the office setting. Practices will receive a stipend to
facilitate data collection for a planned evaluation of the project.
Find out if your practice is eligible to participate.

Who is offering this program?

The American Institutes for Research (AIR) is leading this project in partnership
with the state of Oklahoma, the ECHO Institute at the University of New Mexico
Health Sciences Center, and the American Society of Addiction Medicine. This
project is supported by grant R18HS025067 from the Agency for Healthcare
Research and Quality, an agency of the U.S. Department of Health and Human
Services. (Click here to learn more about partners )


Contact Us


Join Today! To complete our brief eligibility screening form, please visit
https://www.surveymonkey.com/r/OklahomaMAT

Want to learn more about the project? If you'd like to listen to a recording of our informational webinar, entitled "Medication-Assisted Treatment in Rural Oklahoma," please follow this link.Sign up for an informational webinar with the project team and our consulting physicians.


If you have any questions, please contact the AIR team at:
OklahomaMAT@air.org
or, Phone: 866-236-4285

This project is supported by grant number R18HS025067 from the Agency for Healthcare Research and Quality, an agency of the U.S. Department of Health and Human Services. The content of this website is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality.